6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 daahirnimo>98.0% (LCMS) Ensitrelvir (S-217622) Dhexdhexaad COVID-19
Supply Commercial Ensitrelvir (S-217622) Dhexdhexaadiyaha:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
Trimethyloxonium Tetrafluoroborate CAS 420-37-1
6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl) -1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4(1H,3H)-dione, 3- (1,1-dimethylethyl) -6-(ethylthio)- CAS 1360105-53-8
Magaca Kiimikada | 6-Chloro-2-methyl-2H-indazol-5-aamin |
Lambarka CAS | 1893125-36-4 |
Lambarka CAT | RF-PI1506 |
Heerka Saamiyada | In Stock |
Qaanuunka molecular | C8H8ClN3 |
Miisaanka Molecular | 181.62 |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Bunni khafiif ah ilaa budada adag ee cawl |
Daahirnimada / Habka Falanqaynta | >98.0% (LCMS) |
1 H NMR Spectrum | Waafaqsan Qaab-dhismeedka |
LCMS | Waafaqsan Qaab-dhismeedka |
Khasaare xagga qalajinta | ≤1.00% |
Wadarta wasakhda | <2.00% |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyaha Ensitrelvir (S-217622), COVID-19 |
Xidhmada: Dhalo, 25kg/Drum, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka.
6-Chloro-2-methyl-2H-indazol-5-amine (CAS: 1893125-36-4) waa dhexdhexaad ah Ensitrelvir (S-217622).Ensitrelvir ee Shionogi & Co. waa daawo fayruska ka hortag ah oo aad waxtar u leh oo u shaqeysa si la mid ah Pfizer's Paxlovid.Oral Xocova (Ensitrelvir), oo leh habka ficilka ee Pfizer's Paxlovid (Nirmatrelvir + Ritonavir), waxay ku kala duwan tahay in loo baahan yahay oo kaliya in la qaato hal mar maalintii, halka waxtarka daaweynta ee ensitrelvir uusan u muuqan mid ka hooseeya Paxlovid.Xusuusin ahaan, Nirmatrelvir waxaa la maamulaa laba jeer maalintii, oo ay la socoto xoojiye uu matalo Ritonavir.Ensitrelvir wuxuu noqday kiniinkii ugu horreeyay ee Japan ee lagu daweeyo COVID-19, saddexaad oo si nidaamsan loogu oggolaaday Japan;Febraayo 2022.